Drug intelligence / Profile preview

Qidong Huoluo Granule

Development stage
Preclinical
Lead developer
Ruijin Hospital
Administration
Oral
01

Overview

Qidong Huoluo Granule is a traditional Chinese medicine (TCM) compound formulated as a granule, containing ingredients such as Astragalus, Ophiopogon, and other herbs. It is designed by a research team affiliated with traditional medicine in China and administered orally, typically twice daily[1][4]. The compound is used adjunctively in amyotrophic lateral sclerosis (ALS) and has been studied in combination with electroacupuncture. Its purported benefits include stabilization of symptoms related to bulbar paralysis, improvements in swallowing, speech, articulation, and breathing in ALS patients[1][2][4]. Mechanistically, although the precise pharmacological action is not well characterized by modern standards, it is believed to work via antioxidative and anti-inflammatory effects, possibly mitigating neurodegeneration and oxidative stress, and supporting neuronal health through effects observed in metabolomic and gut microbiota studies[4]. The formula does not represent a single chemical entity but rather a multi-herb mixture typical of TCM compounds.

Brand names
Qidong Huoluo Granule
Other names
Qidong Huoluo granuleQidong Huoluo granules

Beyond the preview

Go deeper on Qidong Huoluo Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qidong Huoluo Granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call